Thinking of joining a study?

Register your interest

NCT05550766 | Not yet recruiting | Non-melanoma Skin Cancer


Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma
Sponsor:

Sohag University

Information provided by (Responsible Party):

Fatima Mohammed Hamdan

Brief Summary:

Vitamin D has a crucial role in cancer control and prevention.vitamin D receptor (VDR) and its heterodimer Retinoid X receptor (RXR) are equally important in the cell. This ligand (vitamin D) and receptors (VDR-RXR) complex together triggers downstream DNA damage response in the cell. Retinoid receptors are a superfamily of nuclear receptors. The preferred receptor that attaches to VDR is RXR, with its subunits α, β and γ. RXR α is more frequent in the skin than other tissues, while β occurs in internal organs and γ is frequently related to neural disorders. the investigator hopes to assess prognosis of SCC & BCC by using RXR-α biomarker & attempts to use it in the treatment.

Condition or disease

Non-melanoma Skin Cancer

Study Type : Observational
Estimated Enrollment : 50 participants
Official Title : Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma: An Immunohistochemical Study.
Actual Study Start Date : December 2022
Estimated Primary Completion Date : September 2023
Estimated Study Completion Date : December 2023

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: All
Criteria
Inclusion Criteria
  • Squamous cell carcinoma and basal cell carcinoma.
  • Incisional & excisional biopsies.
  • All the studied cases include sufficient materials for the immunohistochemical study 4. Complete clinical data
Exclusion Criteria
  • Patients with a history of preoperative chemotherapy and/or radiotherapy.
  • Insufficient or tiny tissue biopsies.

Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma

Location Details


Please Choose a site



Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Loading...